The influence of azelnidipine on plasma renin activity and plasma aldosterone concentration in hypertensive patients.

Trial Profile

The influence of azelnidipine on plasma renin activity and plasma aldosterone concentration in hypertensive patients.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 02 Mar 2009

At a glance

  • Drugs Azelnidipine (Primary)
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top